Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00075816 · ClinicalTrials.gov registry record · Phase 3
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)
A Phase 3 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 3
- Development phase
- 551
- Enrollment target
NCT00075816 is a Phase 3 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 551 participants.
The verdict
NCT00075816, a Phase 3 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 551 participants
- Enrollment target
Study Summary
The study is designed as a Phase III, randomized, open label, multicenter, prospective, comparative trial of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells (PBSC) versus marrow from unrelated donors for transplantation in patients with hematologic malignancies. Recipients will be stratified by transplant center and disease risk and will be randomized to either the PBSC or marrow arm in a 1:1 ratio.
Interventions
- BIOLOGICAL Allogeneic bone marrow transplantation
- BIOLOGICAL Peripheral blood stem cell transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 551 participants |
| Start Date | 2004-01 |
| Est. Completion | 2014-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00075816
The ClinicalTrials.gov registry entry for NCT00075816 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 551 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Allogeneic bone marrow transplantation is the first listed.
NCT00075816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00075816 about?
NCT00075816 is a clinical study titled "Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)". The study is designed as a Phase III, randomized, open label, multicenter, prospective, comparative trial of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells (PBSC) versus marrow from unrelated donors for transplantation in patients with hematologic malignancies. R...
What is the current status of trial NCT00075816?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 551 participants. The study started on 2004-01. Estimated completion is 2014-04.
What interventions are being tested in trial NCT00075816?
The interventions under investigation include: Allogeneic bone marrow transplantation (BIOLOGICAL), Peripheral blood stem cell transplantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT00075816?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.